Abstract

Background: Grade 2+ residual mitral regurgitation (MR 2+) is associated with the recurrence of MR and a lower survival rate in interventional mitral valve (MV) edge-to-edge (EE) repair. We sought to determine the MV anatomic factors affecting residual MR 2+ during interventional EE repair with the ValveClamp system in patients with degenerative MR (DMR).Methods: In this multicenter study, 62 patients with significant (grade 3+ to 4+) DMR underwent ValveClamp implantation across eight centers from July 2018 to December 2019. Patient clinical, anatomical, and procedural characteristics were prospectively collected and retrospectively analyzed.Results: A single clamp was implanted in 59 patients, and two clamps were implanted in three patients. Residual MR 2+ was found in 14 patients (22.6%) immediately after the ValveClamp procedure. Patients with residual MR 2+ showed significantly larger preoperative tenting sizes and annular dimensions than the residual MR ≤1+ group. Multivariate analysis identified tenting volume as the major determinant of residual MR 2+ after ValveClamp procedures (odds ratio, 1.410 per 0.1-mL/m2 increase; 95% confidence interval, 1.167–1.705; P < 0.001). Receiver operating characteristic curves identified a tenting volume index ≥0.82 mL/m2 as the optimal cutoff point to predict residual MR 2+ (area under curve, 0.84). Patients with a tenting volume index ≥0.82 mL/m2 were more likely to develop recurrent 3+ MR or undergo MV surgery during short-term follow-up (P < 0.001).Conclusions: Preoperative assessment of the tenting volume index will help to predict intraoperative residual MR 2+ in patients with DMR receiving EE-based interventional repair. Improvements in the interventional strategy are warranted for sustained MR reduction in patients with DMR with unfavorable anatomy.

Highlights

  • Interventional mitral valve (MV) edge-to-edge (EE) repair using the MitraClip system has changed the landscape for the treatment of symptomatic severe mitral regurgitation (MR) [1]

  • After ValveClamp implantation, MR was graded as none or trivial in 22 (35%), mild in 26 (42%), moderate in 12 (19%), and moderate to severe in 2 (3%) patients

  • Size and MV annular diameter and area at baseline, as defined by 3D transesophageal echocardiography (TEE) imaging, among which the tenting volume index was independently associated with residual MR 2+; (b) patients with a tenting volume index ≥0.82 mL/m2 were more likely to have recurrent moderate to severe or greater MR during shortterm follow-up; and (c) multiple clamps might be necessary for patients with a tenting volume index ≥0.82 mL/m2 in order to counteract more severe morphological distortion and achieve optimal results

Read more

Summary

Introduction

Interventional mitral valve (MV) edge-to-edge (EE) repair using the MitraClip system has changed the landscape for the treatment of symptomatic severe mitral regurgitation (MR) [1]. Previous studies have revealed that residual MR ≥2+ after MitraClip implantation is associated with the recurrence of MR and a lower survival rate in degenerative MR (DMR) [2, 3]. It has been suggested that the preoperative 3D echocardiography-derived annular diameter and tenting/tethering size can predict the response to MitraClip implantation in patients with DMR. These studies were limited by mixed or limited study populations, and the results were discordant [9,10,11]. Grade 2+ residual mitral regurgitation (MR 2+) is associated with the recurrence of MR and a lower survival rate in interventional mitral valve (MV) edge-to-edge (EE) repair. We sought to determine the MV anatomic factors affecting residual MR 2+ during interventional EE repair with the ValveClamp system in patients with degenerative MR (DMR)

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call